Vitura HealthASX:VIT 5-Day RSI is 64.87 as of Jul. 06, 2026. The stock has 8 warning signs investors should review. Among 1,042 Drug Manufacturers companies, Vitura Health ranks worse than 61.9% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-06), Vitura Health's 5-Day RSI is 64.87.
The industry rank for Vitura Health's 5-Day RSI or its related term are showing as below:
ASX:VIT's 5-Day RSI is ranked worse than 61.9% of 1042
companies
in the Drug Manufacturers industry
Industry Median: 59.715
vs ASX:VIT: 64.87
Vitura Health (ASX:VIT) 5-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Vitura Health 5-Day RSI Related Terms
ASX:VIT vs ZTS, UTHR: 5-Day RSI Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vitura Health's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitura Health 5-Day RSI vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vitura Health's 5-Day RSI distribution charts can be found below:
* The bar in red indicates where Vitura Health's 5-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vitura Health (ASX:VIT) has a 5-Day RSI of 64.87 as of Jul. 06, 2026. According to the industry distribution chart, Vitura Health ranks #645 out of 1042 companies in the Drug Manufacturers industry, placing it in the top 61.9%.
Is Vitura Health's 5-Day RSI too high?
Vitura Health's current 5-Day RSI is 64.87. The Drug Manufacturers industry median 5-Day RSI is 59.72. Vitura Health's value of 64.87 is 8.6% above this industry median. Based on the distribution chart, Vitura Health ranks #645 out of 1042 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Vitura Health's 5-Day RSI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vitura Health ranks #645 out of 1042 companies for 5-Day RSI. This places Vitura Health in the lower half of its industry. The industry median 5-Day RSI is 59.72. Vitura Health's value of 64.87 is 8.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Day RSI for a Drug Manufacturers company?
The median 5-Day RSI among Drug Manufacturers companies is 59.72, based on 1,042 companies in the industry. Companies in the top quartile (top 25%) have a 5-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 5-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vitura Health's current 5-Day RSI of 64.87 is 8.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Day RSI mean?
A high 5-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median 5-Day RSI is 59.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitura Health's current 5-Day RSI is 64.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitura Health stock overvalued right now?
Based on GuruFocus' analysis, Vitura Health (ASX:VIT) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.10, compared to a current price of A$0.03 — trading 73% below its estimated fair value. The current 5-Day RSI is 64.87 and 8.6% above the Drug Manufacturers industry median of 59.72. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Day RSI calculated?
5-Day RSI is calculated from a company's financial statements. For Vitura Health (ASX:VIT), the current 5-Day RSI is 64.87 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vitura Health Ltd is focused on creating medicinal cannabis products and digital health solutions that connect and strengthen the ecosystem between patients, prescribers, pharmacists, and suppliers. The company has two business segments namely, Sales and distribution (involving the sale and distribution of medical products including medicinal cannabis, psychedelic drugs, and smoking cessation products) and Clinics and services (involving the operation of medicinal cannabis clinics and the provision of related services). The company generates the majority of its revenue from the Sales and distribution segment. Geographically the company generates the majority of its revenue from Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:VIT has been successfully added to your